Skip to main content
FU

Fulcrum Therapeutics

Cambridge, United States
Last funding
$175.0M
Post-IPO EquityDec 2025

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

About Fulcrum Therapeutics

How much funding has Fulcrum Therapeutics raised?

Fulcrum Therapeutics has raised $175.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.

Who are Fulcrum Therapeutics's investors?

Fulcrum Therapeutics's investors include Perceptive Advisors, Foresite Capital, Sanofi, Fidelity, Samsara BioCapital.

Where is Fulcrum Therapeutics headquartered?

Fulcrum Therapeutics is headquartered in Cambridge, United States.

What does Fulcrum Therapeutics do?

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

What stage is Fulcrum Therapeutics at?

Fulcrum Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Fulcrum Therapeutics — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/fulcrum-therapeutics. Accessed November 21, 2026.
APA
VCBacked. (2025). Fulcrum Therapeutics — Funding & Investors. Retrieved November 21, 2026, from https://www.vcbacked.co/company/fulcrum-therapeutics
Wikipedia (cite web)
{{cite web |title=Fulcrum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fulcrum-therapeutics |website=VCBacked |access-date=November 21, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Fulcrum Therapeutics? Request a listing update

Founder contacts
m***@fulcrumtx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →